[go: up one dir, main page]

CN1789287A - Poly-sulfated chondroitin sulfate and preparation method thereof - Google Patents

Poly-sulfated chondroitin sulfate and preparation method thereof Download PDF

Info

Publication number
CN1789287A
CN1789287A CN 200510045393 CN200510045393A CN1789287A CN 1789287 A CN1789287 A CN 1789287A CN 200510045393 CN200510045393 CN 200510045393 CN 200510045393 A CN200510045393 A CN 200510045393A CN 1789287 A CN1789287 A CN 1789287A
Authority
CN
China
Prior art keywords
chondroitin sulfate
polysulfated
preparation
polysulfated chondroitin
precipitate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510045393
Other languages
Chinese (zh)
Inventor
姬胜利
崔慧斐
迟延青
曹吉超
王凤山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong University
Original Assignee
Shandong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong University filed Critical Shandong University
Priority to CN 200510045393 priority Critical patent/CN1789287A/en
Publication of CN1789287A publication Critical patent/CN1789287A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

The invention discloses a ploysulfated chondroitin sulfate, containing glucuronic acid derivant and acetaminogalactose derivant in molecule, the characteristics of the invention comprising: the molecular structure comprises 2-0-sulfuric acid- glucuronic acid- (1->3)-2-N- acetyl group- 2- deoxidation- 4 or 6-0-sulfuric acid galactose, the molecular weight is 1KD-30KD, and the proportion between sulfate radical and carboxylate is 2-4. The invention also discloses a method for preparing the ploysulfated chondroitin sulfate, that is by sulphonating the chondroitin sulfate. The ploysulfated chondroitin sulfate possesses appreciable action of resisting tumour breeding, inhibiting tumour transferring and inhibiting mastocyte pulling-off granule, and etc, the anticoagulating potency<= 10IU/mg, and also possesses strong antiphlogistic and analgesic action.

Description

一种多硫酸化硫酸软骨素及其制备方法A kind of polysulfated chondroitin sulfate and preparation method thereof

技术领域technical field

本发明属于生物医药领域,特别是涉及一种多硫酸化硫酸软骨素及其制备方法。The invention belongs to the field of biomedicine, in particular to a polysulfated chondroitin sulfate and a preparation method thereof.

背景技术Background technique

硫酸软骨素为一类硫酸化的糖胺聚糖类化合物,天然产物的分子量一般在10kD~50kD之间,广泛存在于动物软骨组织中。Chondroitin sulfate is a kind of sulfated glycosaminoglycan compound. The molecular weight of natural products is generally between 10kD and 50kD, and it widely exists in animal cartilage tissue.

国内外研究表明,硫酸软骨素具有较强的降低血液中的甘油三酯和胆固醇的作用,能有效地防止动脉粥样硬化的形成。Petitou等人在美国专利“硫酸皮肤素和硫酸软骨素类硫酸化的糖胺聚糖类衍生物的制备”(Sulfated glycosaminoglycanoidderivatives of the dermatan sulfate and chondroitin sulfate type,专利号US5382570)曾报道了硫酸化硫酸软骨素的制备方法,但该法具有工艺复杂、试剂成本高,不利于工业化生产以及所得产物具有不同的结构和活性等缺点,从而限制了它的应用。Domestic and foreign studies have shown that chondroitin sulfate has a strong effect of lowering blood triglycerides and cholesterol, and can effectively prevent the formation of atherosclerosis. Petitou et al. have reported sulfated sulfate in the U.S. patent "Preparation of sulfated glycosaminoglycan derivatives of dermatan sulfate and chondroitin sulfate" (Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type, Patent No. US5382570) A method for preparing chondroitin, but this method has disadvantages such as complex process, high reagent cost, unfavorable industrial production and different structures and activities of the obtained products, thus limiting its application.

发明内容Contents of the invention

针对现有技术的不足,本发明的目的在于提供一种多硫酸化硫酸软骨素及其制备方法,该方法采用一步化学合成法对天然提取的硫酸软骨素进行结构修饰,制备出一种具有较强的抗炎和镇痛作用的多硫酸化硫酸软骨素。In view of the deficiencies in the prior art, the object of the present invention is to provide a polysulfated chondroitin sulfate and a preparation method thereof, which uses a one-step chemical synthesis method to carry out structural modification to the naturally extracted chondroitin sulfate to prepare a Strong anti-inflammatory and analgesic effects of polysulfated chondroitin sulfate.

本发明所述的多硫酸化硫酸软骨素,分子中含有葡萄糖醛酸衍生物和乙酰氨基半乳糖衍生物,其特征是:分子结构由2-O-硫酸基-葡萄糖醛酸-(1→3)-2-N-乙酰基-2-脱氧-4或6-O-硫酸基半乳糖组成,其化学结构如下:The polysulfated chondroitin sulfate of the present invention contains glucuronic acid derivatives and acetylgalactosamine derivatives in the molecule, and is characterized in that the molecular structure consists of 2-O-sulfate group-glucuronic acid-(1→3 )-2-N-acetyl-2-deoxy-4 or 6-O-sulfate galactose, its chemical structure is as follows:

上述的多硫酸化硫酸软骨素结构,R为SO3或H,n为1至30,多硫酸化硫酸软骨素的分子量为1kD~30kD,其分子结构中硫酸根与羧酸根的比值为2~4。The above polysulfated chondroitin sulfate structure, R is SO 3 or H, n is 1 to 30, the molecular weight of polysulfated chondroitin sulfate is 1kD ~ 30kD, and the ratio of sulfate to carboxylate in its molecular structure is 2 ~ 4.

上述多硫酸化硫酸软骨素的制备方法,包括以下步骤:The preparation method of above-mentioned polysulfated chondroitin sulfate comprises the following steps:

(1)硫酸软骨素的多硫酸化:将硫酸软骨素配成质量百分比浓度为15%~30%的溶液,将氯磺酸∶浓硫酸为1∶0.05~0.1的混酸加入到上述溶液中,使硫酸软骨素质量百分比的终浓度为10%~15%,在温度10℃~70℃,搅拌反应2~10小时,然后加入有机溶剂终止反应,得多硫酸化硫酸软骨素沉淀物;(1) The polysulfation of chondroitin sulfate: chondroitin sulfate is made into the solution that mass percentage concentration is 15%~30%, with chlorosulfonic acid: the mixed acid that concentrated sulfuric acid is 1: 0.05~0.1 joins in the above-mentioned solution, The final concentration of chondroitin sulfate by mass percentage is 10% to 15%, at a temperature of 10°C to 70°C, stirring and reacting for 2 to 10 hours, and then adding an organic solvent to terminate the reaction, so that more sulfated chondroitin sulfate precipitates;

(2)分离所需要的多硫酸化硫酸软骨素片段:将上述沉淀物配成水溶液,调pH至7±0.2,加入其4~5倍量的有机溶剂使之沉淀;再将沉淀物配成水溶液,用碱调pH至10±0.2,加热至85℃±2℃,并不断进行反应器内的气体交换,保温3±0.5小时,然后用盐酸调pH至7,加入其4~5倍量有机溶剂使之沉淀,实现脱盐和除胺;(2) Separation of the required polysulfated chondroitin sulfate fragments: make the above precipitate into an aqueous solution, adjust the pH to 7±0.2, add 4 to 5 times the amount of organic solvent to precipitate it; then make the precipitate into Aqueous solution, adjust pH to 10±0.2 with alkali, heat to 85℃±2℃, and continuously carry out gas exchange in the reactor, keep warm for 3±0.5 hours, then adjust pH to 7 with hydrochloric acid, add 4 to 5 times the amount Precipitate with organic solvent to realize desalination and amine removal;

(3)收集、制备多硫酸化硫酸软骨素:将步骤(2)最终获得的沉淀物配成质量百分比浓度为10%水溶液,进行凝胶层析法分离,以浓度为0.01~1.0mol/L的氯化钠溶液进行洗脱,收集多硫酸化硫酸软骨素含量高的部分,用Sephadex G-10脱盐,常规冷冻干燥得多硫酸化硫酸软骨素。(3) Collecting and preparing polysulfated chondroitin sulfate: the precipitate finally obtained in step (2) is made into an aqueous solution with a concentration of 10% by mass, and is separated by gel chromatography to a concentration of 0.01 to 1.0 mol/L The sodium chloride solution was used for elution, and the part with high content of polysulfated chondroitin sulfate was collected, desalted with Sephadex G-10, and conventionally freeze-dried polysulfated chondroitin sulfate.

在上述的多硫酸化硫酸软骨素的制备方法中,步骤(1)所述氯磺酸∶浓硫酸优选为1∶0.05~0.07。In the above-mentioned preparation method of polysulfated chondroitin sulfate, the ratio of chlorosulfonic acid:concentrated sulfuric acid in step (1) is preferably 1:0.05-0.07.

在上述的多硫酸化硫酸软骨素的制备方法中,步骤(1)所述反应温度优选是30℃~40℃,搅拌时间优选是4~6小时。In the above-mentioned preparation method of polysulfated chondroitin sulfate, the reaction temperature in step (1) is preferably 30°C-40°C, and the stirring time is preferably 4-6 hours.

在上述的多硫酸化硫酸软骨素的制备方法中,步骤(1)或(2)所述有机溶剂是甲醇、乙醇、丙酮、异丙醇之一。In the above method for preparing polysulfated chondroitin sulfate, the organic solvent in step (1) or (2) is one of methanol, ethanol, acetone, and isopropanol.

其中,上述有机溶剂优选是体积百分比浓度为95%的乙醇。Wherein, the above-mentioned organic solvent is preferably ethanol with a concentration of 95% by volume.

在上述的多硫酸化硫酸软骨素的制备方法中,步骤(3)所述凝胶层析法中,采用的凝胶为Sephadex G-50、Sephadex G-75、Sephadex G-100、Superdex 200之一。In the preparation method of the above-mentioned polysulfated chondroitin sulfate, in the gel chromatography described in step (3), the gel used is one of Sephadex G-50, Sephadex G-75, Sephadex G-100, Superdex 200 one.

其中,所述凝胶优选为3.5×120cm的Sephadex G-75凝胶柱。Wherein, the gel is preferably a Sephadex G-75 gel column of 3.5 × 120 cm.

在上述的多硫酸化硫酸软骨素的制备方法中,步骤(3)所述洗脱液优选是浓度为0.2~0.5mol/L的氯化钠溶液。In the above method for preparing polysulfated chondroitin sulfate, the eluent in step (3) is preferably a sodium chloride solution with a concentration of 0.2-0.5 mol/L.

本发明所述的多硫酸化硫酸软骨素的制备方法,具有工艺简单、试剂成本低,生产环境及设备要求不苛刻,且产品纯度高的特点,极利于工业化生产。The preparation method of the polysulfated chondroitin sulfate of the present invention has the characteristics of simple process, low reagent cost, less stringent production environment and equipment requirements, and high product purity, which is extremely beneficial to industrial production.

本发明所述方法制得的多硫酸化硫酸软骨素具有较强的抗炎和镇痛作用。经试验验证,其抗凝效价≤10IU/mg,并且还具有明显的抗肿瘤增殖和抑制肿瘤转移、抑制肥大细胞脱颗粒等作用。The polysulfated chondroitin sulfate prepared by the method of the invention has strong anti-inflammatory and analgesic effects. It has been verified by experiments that its anticoagulant potency is ≤10IU/mg, and it also has obvious effects of anti-tumor proliferation, inhibition of tumor metastasis, and inhibition of mast cell degranulation.

具体实施方式Detailed ways

下面结合实施例对本发明所述内容作进一步阐述。The content of the present invention will be further elaborated below in conjunction with the embodiments.

实施例1Example 1

(1)硫酸软骨素的多硫酸化:将硫酸软骨素精品(市售)100g配成质量百分比浓度为20%的溶液,将氯磺酸∶浓硫酸为1∶0.05的混酸加入到上述溶液中,使硫酸软骨素质量百分比的终浓度为10%,在温度35℃,搅拌反应5小时,然后加入4000ml无水乙醇终止反应,得多硫酸化硫酸软骨素沉淀物;(1) Polysulfation of chondroitin sulfate: 100 g of chondroitin sulfate boutique (commercially available) is made into a solution with a mass percent concentration of 20%, and chlorosulfonic acid: concentrated sulfuric acid is 1: 0.05 mixed acid is added in the above solution , so that the final concentration of chondroitin sulfate mass percent is 10%, at a temperature of 35° C., stirring and reacting for 5 hours, then adding 4000 ml of absolute ethanol to terminate the reaction, and there will be more sulfated chondroitin sulfate precipitates;

(2)分离所需要的多硫酸化硫酸软骨素片段:将上述沉淀物用1000ml蒸馏水溶解,配成水溶液,用20%氢氧化钠调pH至7,加入其4倍量的95%乙醇使之沉淀;再将沉淀物配成10%水溶液,用20%氢氧化钠调pH至10,加热至85℃,并不断进行反应器内的气体交换,保温3小时,然后用6mol/L盐酸调pH至7,加入其4倍量95%7醇使之沉淀,实现脱盐和除胺;(2) Separation of the required polysulfated chondroitin sulfate fragments: Dissolve the above precipitate with 1000ml distilled water to make an aqueous solution, adjust the pH to 7 with 20% sodium hydroxide, add 4 times the amount of 95% ethanol to make it Precipitation; then make the precipitate into a 10% aqueous solution, adjust the pH to 10 with 20% sodium hydroxide, heat to 85°C, and continuously perform gas exchange in the reactor, keep it warm for 3 hours, and then adjust the pH with 6mol/L hydrochloric acid To 7, add 4 times the amount of 95% 7 alcohol to precipitate it to achieve desalination and amine removal;

(3)收集、制备多硫酸化硫酸软骨素:将步骤(2)最终获得的沉淀物配成质量百分比浓度为10%水溶液,上Sephadex G-75凝胶柱(3.5×120cm)分离,以浓度为0.2mol/L的氯化钠溶液进行洗脱,收集多硫酸化硫酸软骨素含量高的部分,用Sephadex G-10脱盐,常规冷冻干燥得多硫酸化硫酸软骨素。(3) Collection and preparation of polysulfated chondroitin sulfate: the precipitate finally obtained in step (2) is made into a 10% aqueous solution with a concentration of 10% by mass, and separated on a Sephadex G-75 gel column (3.5 × 120cm), and the concentration is It was eluted with 0.2mol/L sodium chloride solution, and the part with high content of polysulfated chondroitin sulfate was collected, desalted with Sephadex G-10, and conventionally freeze-dried polysulfated chondroitin sulfate.

将上述所得的多硫酸化硫酸软骨素分别进行分子量测定、结构测定和抗炎活性测定得到一种多硫酸化硫酸软骨素,分子中含有葡萄糖醛酸衍生物和乙酰氨基半乳糖衍生物,分子结构由2-O-硫酸基-葡萄糖醛酸-(1→3)-2-N-乙酰基-2-脱氧-4 or 6-O-硫酸基半乳糖组成,其主要化学结构如下:The polysulfated chondroitin sulfate obtained above is subjected to molecular weight determination, structure determination and anti-inflammatory activity determination respectively to obtain a polysulfated chondroitin sulfate, which contains glucuronic acid derivatives and acetylgalactosamine derivatives in the molecule, and the molecular structure Composed of 2-O-sulfate-glucuronic acid-(1→3)-2-N-acetyl-2-deoxy-4 or 6-O-sulfate galactose, its main chemical structure is as follows:

Figure A20051004539300061
Figure A20051004539300061

该多硫酸化硫酸软骨素的相对分子量为1kD~30kD,R为SO3或H,n为1至30,硫酸根与羧酸根的比值为2~4,具有明显的抑制肥大细胞脱颗粒作用,抗凝效价≤10IU/mg。还具有明显的抗肿瘤增殖和抑制肿瘤转移等作用,有较强的抗炎和镇痛作用。The polysulfated chondroitin sulfate has a relative molecular weight of 1kD to 30kD, R is SO3 or H, n is 1 to 30, the ratio of sulfate to carboxylate is 2 to 4, and has obvious inhibitory effect on mast cell degranulation, Anticoagulant titer ≤ 10IU/mg. It also has obvious anti-tumor proliferation and inhibition of tumor metastasis, etc., and has strong anti-inflammatory and analgesic effects.

实施例2Example 2

(1)硫酸软骨素的多硫酸化:将硫酸软骨素精品(市售)200g配成质量百分比浓度为30%的溶液,将氯磺酸∶浓硫酸为1∶0.07的混酸加入到上述溶液中,使硫酸软骨素质量百分比的终浓度为10%,在温度40℃,搅拌反应6小时,然后加入4000ml无水乙醇终止反应,得多硫酸化硫酸软骨素沉淀物;(1) Polysulfation of chondroitin sulfate: 200 g of chondroitin sulfate boutique (commercially available) is made into a solution with a mass percentage concentration of 30%, and chlorosulfonic acid: concentrated sulfuric acid is 1: 0.07 mixed acid is added in the above solution , so that the final concentration of chondroitin sulfate mass percent is 10%, at a temperature of 40 ° C, stirring and reacting for 6 hours, then adding 4000ml of absolute ethanol to terminate the reaction, and more sulfated chondroitin sulfate precipitates;

(2)分离所需要的多硫酸化硫酸软骨素片段:将上述沉淀物用1000ml蒸馏水溶解,配成水溶液,用20%氢氧化钠调pH至7,加入其5倍量的95%甲醇使之沉淀;再将沉淀物配成10%水溶液,用20%氢氧化钠调pH至10,加热至85℃,并不断进行反应器内的气体交换,保温3.5小时,然后用6mol/L盐酸调pH至7,加入其5倍量95%甲醇使之沉淀,实现脱盐和除胺;(2) Separation of the required polysulfated chondroitin sulfate fragments: Dissolve the above precipitate with 1000ml distilled water to make an aqueous solution, adjust the pH to 7 with 20% sodium hydroxide, and add 5 times the amount of 95% methanol to make it Precipitation; then make the precipitate into a 10% aqueous solution, adjust the pH to 10 with 20% sodium hydroxide, heat to 85°C, and continuously perform gas exchange in the reactor, keep it warm for 3.5 hours, and then adjust the pH with 6mol/L hydrochloric acid To 7, add 5 times the amount of 95% methanol to precipitate it to achieve desalination and amine removal;

(3)收集、制备多硫酸化硫酸软骨素:将步骤(2)最终获得的沉淀物配成质量百分比浓度为10%水溶液,上Sephadex G-100凝胶柱(3.5×120cm)分离,以浓度为0.5mol/L的氯化钠溶液进行洗脱,收集多硫酸化硫酸软骨素含量高的部分,用Sephadex G-10脱盐,常规冷冻干燥得多硫酸化硫酸软骨素。(3) Collecting and preparing polysulfated chondroitin sulfate: the precipitate finally obtained in step (2) is made into a 10% aqueous solution with a concentration of 10% by mass, separated on a Sephadex G-100 gel column (3.5 × 120cm), and separated by concentration It was eluted with 0.5mol/L sodium chloride solution, and the part with high content of polysulfated chondroitin sulfate was collected, desalted with Sephadex G-10, and routinely freeze-dried polysulfated chondroitin sulfate.

实施例3Example 3

(1)硫酸软骨素的多硫酸化:将硫酸软骨素精品(市售)100g配成质量百分比浓度为25%的溶液,将氯磺酸∶浓硫酸为1∶0.09的混酸加入到上述溶液中,使硫酸软骨素质量百分比的终浓度为10%,在温度30℃,搅拌反应10小时,然后加入4000ml丙酮终止反应,得多硫酸化硫酸软骨素沉淀物;(1) Polysulfation of chondroitin sulfate: 100 g of chondroitin sulfate boutique (commercially available) is made into a solution with a mass percentage concentration of 25%, and chlorosulfonic acid: concentrated sulfuric acid is 1: 0.09 mixed acid is added in the above solution , making the final concentration of chondroitin sulfate mass percent 10%, at a temperature of 30° C., stirring and reacting for 10 hours, then adding 4000 ml of acetone to terminate the reaction, resulting in more sulfated chondroitin sulfate precipitates;

(2)分离所需要的多硫酸化硫酸软骨素片段:将上述沉淀物用1000ml蒸馏水溶解,配成水溶液,用20%氢氧化钠调pH至7,加入其4倍量的丙酮使之沉淀;再将沉淀物配成10%水溶液,用20%氢氧化钠调pH至10,加热至85℃,并不断进行反应器内的气体交换,保温3小时,然后用6mol/L盐酸调pH至7,加入其4倍量丙酮使之沉淀,实现脱盐和除胺;(2) Separation of the required polysulfated chondroitin sulfate fragments: dissolve the above precipitate with 1000ml of distilled water to make an aqueous solution, adjust the pH to 7 with 20% sodium hydroxide, add 4 times the amount of acetone to make it precipitate; Then make the precipitate into 10% aqueous solution, adjust the pH to 10 with 20% sodium hydroxide, heat to 85°C, and continuously carry out gas exchange in the reactor, keep it warm for 3 hours, then adjust the pH to 7 with 6mol/L hydrochloric acid , add 4 times the amount of acetone to precipitate it, to achieve desalination and amine removal;

(3)收集、制备多硫酸化硫酸软骨素:将步骤(2)最终获得的沉淀物配成质量百分比浓度为10%水溶液,上Sephadex G-50凝胶柱(3.5×120cm)分离,以浓度为0.8mol/L的氯化钠溶液进行洗脱,收集多硫酸化硫酸软骨素含量高的部分,用Sephadex G-10脱盐,常规冷冻干燥得多硫酸化硫酸软骨素。(3) Collecting and preparing polysulfated chondroitin sulfate: the precipitate finally obtained in step (2) is made into a 10% aqueous solution with a concentration of 10% by mass, and separated on a Sephadex G-50 gel column (3.5 × 120cm) to determine the concentration It was eluted with 0.8mol/L sodium chloride solution, and the part with high content of polysulfated chondroitin sulfate was collected, desalted with Sephadex G-10, and conventionally freeze-dried polysulfated chondroitin sulfate.

Claims (10)

1.一种多硫酸化硫酸软骨素,分子中含有葡萄糖醛酸衍生物和乙酰氨基半乳糖衍生物,其特征是:分子结构由2-O-硫酸基-葡萄糖醛酸-(1→3)-2-N-乙酰基-2-脱氧-4或6-O-硫酸基半乳糖组成,其化学结构如下:1. A polysulfated chondroitin sulfate, containing glucuronic acid derivatives and acetylgalactosamine derivatives in the molecule, is characterized in that: molecular structure is by 2-O-sulfate group-glucuronic acid-(1→3) -2-N-acetyl-2-deoxy-4 or 6-O-sulfate galactose, its chemical structure is as follows:
Figure A2005100453930002C1
Figure A2005100453930002C1
其中:R为SO3或H,n为1至30。Wherein: R is SO 3 or H, and n is 1 to 30.
2.根据权利要求1所述的多硫酸化硫酸软骨素,其特征是:所述多硫酸化硫酸软骨素的分子量为1kD~30kD,其分子结构中硫酸根与羧酸根的比值为2~4。2. polysulfated chondroitin sulfate according to claim 1 is characterized in that: the molecular weight of described polysulfated chondroitin sulfate is 1kD~30kD, and the ratio of sulfate and carboxylate in its molecular structure is 2~4 . 3.权利要求1或2所述多硫酸化硫酸软骨素的制备方法,包括以下步骤:3. the preparation method of polysulfated chondroitin sulfate described in claim 1 or 2, comprises the following steps: (1)硫酸软骨素的多硫酸化:将硫酸软骨素配成质量百分比浓度为15%~30%的溶液,将氯磺酸∶浓硫酸为1∶0.05~0.1的混酸加入到上述溶液中,使硫酸软骨素质量百分比的终浓度为10%~15%,在温度10℃~70℃,搅拌反应2~10小时,然后加入有机溶剂终止反应,得多硫酸化硫酸软骨素沉淀物;(1) The polysulfation of chondroitin sulfate: chondroitin sulfate is made into the solution that mass percentage concentration is 15%~30%, with chlorosulfonic acid: the mixed acid that concentrated sulfuric acid is 1: 0.05~0.1 joins in the above-mentioned solution, The final concentration of chondroitin sulfate by mass percentage is 10% to 15%, at a temperature of 10°C to 70°C, stirring and reacting for 2 to 10 hours, and then adding an organic solvent to terminate the reaction, so that more sulfated chondroitin sulfate precipitates; (2)分离所需要的多硫酸化硫酸软骨素片段:将上述沉淀物配成水溶液,调pH至7±0.2,加入其4~5倍量的有机溶剂使之沉淀;再将沉淀物配成水溶液,用碱调pH至10±0.2,加热至85℃±2℃,并不断进行反应器内的气体交换,保温3±0.5小时,然后用盐酸调pH至7,加入其4~5倍量有机溶剂使之沉淀,实现脱盐和除胺;(2) Separation of the required polysulfated chondroitin sulfate fragments: make the above precipitate into an aqueous solution, adjust the pH to 7±0.2, add 4 to 5 times the amount of organic solvent to precipitate it; then make the precipitate into Aqueous solution, adjust pH to 10±0.2 with alkali, heat to 85℃±2℃, and continuously carry out gas exchange in the reactor, keep warm for 3±0.5 hours, then adjust pH to 7 with hydrochloric acid, add 4 to 5 times the amount Precipitate with organic solvent to realize desalination and amine removal; (3)收集、制备多硫酸化硫酸软骨素:将步骤(2)最终获得的沉淀物配成质量百分比浓度为10%水溶液,进行凝胶层析法分离,以浓度为0.01~1.0mol/L的氯化钠溶液进行洗脱,收集多硫酸化硫酸软骨素含量高的部分,用Sephadex G-10脱盐,常规冷冻干燥得多硫酸化硫酸软骨素。(3) Collecting and preparing polysulfated chondroitin sulfate: the precipitate finally obtained in step (2) is made into an aqueous solution with a concentration of 10% by mass, and is separated by gel chromatography to a concentration of 0.01 to 1.0 mol/L The sodium chloride solution was used for elution, and the part with high content of polysulfated chondroitin sulfate was collected, desalted with Sephadex G-10, and conventionally freeze-dried polysulfated chondroitin sulfate. 4.根据权利要求3所述的多硫酸化硫酸软骨素的制备方法,其特征是:步骤(1)所述氯磺酸∶浓硫酸为1∶0.05~0.07。4. the preparation method of polysulfated chondroitin sulfate according to claim 3 is characterized in that: the chlorosulfonic acid described in step (1): concentrated sulfuric acid is 1: 0.05~0.07. 5.根据权利要求3所述的多硫酸化硫酸软骨素的制备方法,其特征是:步骤(1)所述反应温度是30℃~40℃,搅拌时间是4~6小时。5. The preparation method of polysulfated chondroitin sulfate according to claim 3, characterized in that: the reaction temperature in step (1) is 30°C to 40°C, and the stirring time is 4 to 6 hours. 6.根据权利要求3所述的多硫酸化硫酸软骨素的制备方法,其特征是:步骤(1)或(2)所述有机溶剂是甲醇、乙醇、丙酮、异丙醇之一。6. the preparation method of polysulfated chondroitin sulfate according to claim 3 is characterized in that: the organic solvent described in step (1) or (2) is one of methanol, ethanol, acetone, Virahol. 7.根据权利要求6所述的多硫酸化硫酸软骨素的制备方法,其特征是:所述有机溶剂是体积百分比浓度为95%的乙醇。7. the preparation method of polysulfated chondroitin sulfate according to claim 6 is characterized in that: described organic solvent is the ethanol that volume percent concentration is 95%. 8.根据权利要求3所述的多硫酸化硫酸软骨素的制备方法,其特征是:步骤(3)所述凝胶层析法中,采用的凝胶为Sephadex G-50、Sephadex G-75、Sephadex G-100、Superdex200之一。8. the preparation method of polysulfated chondroitin sulfate according to claim 3 is characterized in that: in the gel chromatography described in step (3), the gel that adopts is Sephadex G-50, Sephadex G-75 , Sephadex G-100, one of Superdex200. 9.根据权利要求8所述的多硫酸化硫酸软骨素的制备方法,其特征是:所述凝胶为3.5×120cm的Sephadex G-75凝胶柱。9. the preparation method of polysulfated chondroitin sulfate according to claim 8 is characterized in that: the gel is a Sephadex G-75 gel column of 3.5 * 120cm. 10.根据权利要求3所述的多硫酸化硫酸软骨素的制备方法,其特征是:步骤(3)所述洗脱液是浓度为0.2~0.5mol/L的氯化钠溶液。10. The preparation method of polysulfated chondroitin sulfate according to claim 3, characterized in that: the eluent in step (3) is a sodium chloride solution with a concentration of 0.2 to 0.5 mol/L.
CN 200510045393 2005-12-20 2005-12-20 Poly-sulfated chondroitin sulfate and preparation method thereof Pending CN1789287A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510045393 CN1789287A (en) 2005-12-20 2005-12-20 Poly-sulfated chondroitin sulfate and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510045393 CN1789287A (en) 2005-12-20 2005-12-20 Poly-sulfated chondroitin sulfate and preparation method thereof

Publications (1)

Publication Number Publication Date
CN1789287A true CN1789287A (en) 2006-06-21

Family

ID=36787432

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510045393 Pending CN1789287A (en) 2005-12-20 2005-12-20 Poly-sulfated chondroitin sulfate and preparation method thereof

Country Status (1)

Country Link
CN (1) CN1789287A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102125543A (en) * 2011-02-28 2011-07-20 王啸龙 Heparin-free anticoagulant infection inhibitor for hemodialysis and preparation method thereof
CN103582653A (en) * 2011-05-12 2014-02-12 诺西斯有限公司 Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof
WO2016197799A1 (en) * 2015-06-10 2016-12-15 浙江三门恒康制药有限公司 Method for preparing heparinoid
CN108752500A (en) * 2018-07-03 2018-11-06 江南大学 A method of preparing curdlan sulfuric ester
CN109970882A (en) * 2019-03-08 2019-07-05 河北常山生化药业股份有限公司 A kind of preparation method of poly-sulfated chondroitin sulfate
CN113631584A (en) * 2019-03-05 2021-11-09 中国医学科学院药物研究所 Chondroitin sulfate polysaccharide, its semi-synthetic preparation method and application
CN117304356A (en) * 2023-08-22 2023-12-29 重庆望业药物研究有限公司 Crystalline form A of polysulfonic acid mucopolysaccharide and its preparation method and application

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102125543A (en) * 2011-02-28 2011-07-20 王啸龙 Heparin-free anticoagulant infection inhibitor for hemodialysis and preparation method thereof
CN103582653A (en) * 2011-05-12 2014-02-12 诺西斯有限公司 Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof
CN103582653B (en) * 2011-05-12 2016-08-17 诺西斯有限公司 4 or 6 Sulfated chondroitin sulfates of biotechnology at same polysaccharide chain and preparation method thereof
WO2016197799A1 (en) * 2015-06-10 2016-12-15 浙江三门恒康制药有限公司 Method for preparing heparinoid
CN108752500A (en) * 2018-07-03 2018-11-06 江南大学 A method of preparing curdlan sulfuric ester
CN113631584A (en) * 2019-03-05 2021-11-09 中国医学科学院药物研究所 Chondroitin sulfate polysaccharide, its semi-synthetic preparation method and application
CN113631584B (en) * 2019-03-05 2023-09-29 中国医学科学院药物研究所 Chondroitin sulfate polysaccharide, its semi-synthetic preparation method and application
CN109970882A (en) * 2019-03-08 2019-07-05 河北常山生化药业股份有限公司 A kind of preparation method of poly-sulfated chondroitin sulfate
CN117304356A (en) * 2023-08-22 2023-12-29 重庆望业药物研究有限公司 Crystalline form A of polysulfonic acid mucopolysaccharide and its preparation method and application

Similar Documents

Publication Publication Date Title
TWI510501B (en) Method for manufacturing purified hyaluronic acid group
US8193166B2 (en) Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
KR910006809B1 (en) Process for the preparation of neutral heparan sulphate and dermatan sulphate
CN1789287A (en) Poly-sulfated chondroitin sulfate and preparation method thereof
CN106832020A (en) A kind of preparation technology of maize straw Pentosan sulphate
US10494452B2 (en) Low-molecular-weight glycosaminoglycan derivative containing terminal 2, 5-anhydrated talose or derivative thereof
JP6486554B2 (en) Method for producing heparinoid
CN104710539A (en) Sulfate fucosan and preparation method thereof
CN1916030A (en) K5 polysaccharide hypersulfated derivatives and preparation method thereof
CN1763212A (en) Process for preparing fucoidan by enzymatic hydrolysis of brown algae
CN109762079B (en) Method for separating and purifying sulodexide bulk drug from heparin by-product
CN1259143A (en) Oligosaccharide mixtures having antithrombotic activity
CN1844165A (en) Process for preparing high purity sodium heparin by purification of crude sodium heparin
EP0386053A1 (en) Non-anticoagulant heparan sulfate, process for extraction from organs, and pharmaceutical compositions thereof.
CN106188341B (en) Heparin sodium leftover bits and pieces prepares high-purity sulfuric acid dermatan technique
JP2003528945A (en) Glycosaminoglycan derived from K5 polysaccharide having high anticoagulant activity and antithrombotic activity and method for preparing the same
CN1350000A (en) Prepn of aminoglucose sulfate
CN1302818A (en) Human chorionic gonadotropin and its preparing process
US7812151B2 (en) Low molecular weight polysaccharides having antithrombotic activity
CN1213071C (en) A kind of ancient sugar ester and its preparation method and application
CN1670028A (en) Preparation method of L-fucose in kelp
CN106749758A (en) Diluted alkaline-enzymolysis-resin adsorption extraction method extracts the chondroitin sulfate in hog snout bone
CN101077891A (en) Sepia polysaccharide sulfated derivative and preparing method thereof
CN1486993A (en) Prepn process of chondroitin sulfate with medium molecule weight
CN1544477A (en) Sulfated lacquer polysaccharide and its preparation method and use

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication